CGC Stock Overview
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Canopy Growth Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$3.79 |
| 52 Week High | CA$14.92 |
| 52 Week Low | CA$2.76 |
| Beta | 1.78 |
| 11 Month Change | -14.64% |
| 3 Month Change | -40.50% |
| 1 Year Change | -35.75% |
| 33 Year Change | -96.75% |
| 5 Year Change | -97.95% |
| Change since IPO | -88.52% |
Recent News & Updates
Avoid Canopy Growth
Nov 10Canopy Growth: Weak Fundamentals And Growth Acceleration Challenges
Oct 05Canopy Growth: Dilution, Executive Turnover, Cannabis Rescheduling Delay End High
Aug 27Recent updates
Avoid Canopy Growth
Nov 10Canopy Growth: Weak Fundamentals And Growth Acceleration Challenges
Oct 05Canopy Growth: Dilution, Executive Turnover, Cannabis Rescheduling Delay End High
Aug 27Canopy Growth: Cannabis Rally Loses Steam On Long-Term Uncertainty (Hold)
Jun 17Canopy Growth: Another Ugly Cannabis Report
Jun 03Canopy Growth Set For U.S. Cannabis Markets
Apr 26Canopy Growth Is Climbing, But It Won't Last
Mar 22Canopy Growth: Reiterate Strong Sell, Dilutive Offering Likely First Of Many To Come
Feb 06Canopy Growth: Further Implosion Is Now A Matter Of When Not If
Jan 29Avoid Canopy Growth After Failed Equity Sale
Jan 14Canopy Growth (Nasdaq:CGC): Further Dilution Seems Inevitable
Oct 13
Canopy Growth: Getting High
Oct 07Quick Takes: Tesla, Twitter, Carvana & More
Oct 06
Canopy Growth to sell Canadian retail operations, including Tokyo Smoke stores
Sep 27Canopy Growth: BioSteel Sizzles, Everything Else Fizzles
Aug 30What Is Canopy Growth's Stock Outlook After Earnings Miss?
Aug 23Canopy Growth leads cannabis rally as Senator backs compromise legislation
Aug 08Canopy gains 12% to lead Canadian cannabis rally as former Aphria legal chief joins
Aug 02Canopy Growth: Constellation's Investment Goes Up In Smoke
Jul 18Canopy Growth: Bankruptcy Risks Are Growing Like A Weed
Jun 28Shareholder Returns
| CGC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -6.2% | -7.0% | -2.1% |
| 1Y | -35.8% | 8.5% | 29.7% |
Return vs Industry: CGC underperformed the US Pharmaceuticals industry which returned 8.5% over the past year.
Return vs Market: CGC underperformed the US Market which returned 29.7% over the past year.
Price Volatility
| CGC volatility | |
|---|---|
| CGC Average Weekly Movement | 11.6% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CGC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CGC's weekly volatility has decreased from 22% to 12% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,029 | David Klein | www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices.
Canopy Growth Corporation Fundamentals Summary
| CGC fundamental statistics | |
|---|---|
| Market cap | US$390.36m |
| Earnings (TTM) | -US$415.70m |
| Revenue (TTM) | US$199.09m |
2.0x
P/S Ratio-1.0x
P/E RatioIs CGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CGC income statement (TTM) | |
|---|---|
| Revenue | CA$280.50m |
| Cost of Revenue | CA$193.61m |
| Gross Profit | CA$86.89m |
| Other Expenses | CA$672.58m |
| Earnings | -CA$585.69m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.56 |
| Gross Margin | 30.98% |
| Net Profit Margin | -208.81% |
| Debt/Equity Ratio | 108.7% |
How did CGC perform over the long term?
See historical performance and comparison